UK markets open in 7 hours 50 minutes

Dr. Martens plc (DOCSL.XC)

Cboe UK - Cboe UK Real-time price. Currency in GBp (0.01 GBP)
Add to watchlist
74.47+0.38 (+0.51%)
At close: 04:29PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 709.67M
Enterprise value 1.07B
Trailing P/E 10.59
Forward P/E 24.75
PEG ratio (5-yr expected) 0.04
Price/sales (ttm)0.83
Price/book (mrq)1.94
Enterprise value/revenue 1.22
Enterprise value/EBITDA 5.44

Trading information

Stock price history

Beta (5Y monthly) 0.10
52-week change 3-36.50%
S&P500 52-week change 325.51%
52-week high 3161.05
52-week low 362.40
50-day moving average 380.66
200-day moving average 394.63

Share statistics

Avg vol (3-month) 3169.23k
Avg vol (10-day) 3111.76k
Shares outstanding 5961.61M
Implied shares outstanding 6963.43M
Float 8515.29M
% held by insiders 14.35%
% held by institutions 170.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.03
Forward annual dividend yield 43.44%
Trailing annual dividend rate 30.03
Trailing annual dividend yield 30.04%
5-year average dividend yield 4N/A
Payout ratio 483.43%
Dividend date 3N/A
Ex-dividend date 429 Aug 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.89%
Operating margin (ttm)17.89%

Management effectiveness

Return on assets (ttm)8.12%
Return on equity (ttm)17.92%

Income statement

Revenue (ttm)877.1M
Revenue per share (ttm)0.89
Quarterly revenue growth (yoy)-17.30%
Gross profit (ttm)N/A
EBITDA 141.7M
Net income avi to common (ttm)69.2M
Diluted EPS (ttm)0.07
Quarterly earnings growth (yoy)-40.40%

Balance sheet

Total cash (mrq)111.1M
Total cash per share (mrq)0.12
Total debt (mrq)477M
Total debt/equity (mrq)129.55%
Current ratio (mrq)2.85
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)167.9M
Levered free cash flow (ttm)100.88M